Moderna (MRNA) Gains After Crushing Estimates on Surging COVID-19 Vaccine Sales
Go back to Moderna (MRNA) Gains After Crushing Estimates on Surging COVID-19 Vaccine Sales| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 79.76 +7.26 (10.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.50 | 52 Week High | $0.52 | |||
| Open | $73.71 | 52 Week Low | $0.08 | |||
| Day High | $81.40 | P/E | N/A | |||
| Day Low | $73.68 | EPS | $-3.80 | |||
| Volume | 14,112,278 | |||||
